Amy Laverdiere

Amy Laverdiere currently serves as the Sr. Director of Program Management at Vera Therapeutics, Inc., since September 2025. Previously, Amy held the position of Program Lead for MDMA at Lykos Therapeutics, where responsibilities included leading the NDA submission for MDMA-assisted therapy for PTSD. With extensive experience at companies such as Aimmune Therapeutics, Cytokinetics, Thoratec, Medtronic, Hatteras Venture Partners, Genentech, and Genzyme Transgenics, Amy has demonstrated a strong background in program management, marketing, product development, and strategic planning across various therapeutic areas. Amy's educational background includes a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology and an MBA in Health Sector Management from Duke University.